Primary Double-Strike Therapy for Cancers to Overcome EGFR Kinase Inhibitor Resistance: Proposal from the Bench.

MLA

Suda, Kenichi, et al. “Primary Double-Strike Therapy for Cancers to Overcome EGFR Kinase Inhibitor Resistance: Proposal from the Bench.” Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, vol. 12, no. 1, Jan. 2017, pp. 27–35. EBSCOhost, https://doi.org/10.1016/j.jtho.2016.09.003.

APA

Suda, K., Bunn, P. A., Jr, Rivard, C. J., Mitsudomi, T., & Hirsch, F. R. (2017). Primary Double-Strike Therapy for Cancers to Overcome EGFR Kinase Inhibitor Resistance: Proposal from the Bench. Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, 12(1), 27–35. https://doi.org/10.1016/j.jtho.2016.09.003

Chicago

Suda, Kenichi, Paul A Bunn Jr, Christopher J Rivard, Tetsuya Mitsudomi, and Fred R Hirsch. 2017. “Primary Double-Strike Therapy for Cancers to Overcome EGFR Kinase Inhibitor Resistance: Proposal from the Bench.” Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer 12 (1): 27–35. doi:10.1016/j.jtho.2016.09.003.